These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 15021898)

  • 1. Epstein-Barr virus oncogenesis and the ubiquitin-proteasome system.
    Masucci MG
    Oncogene; 2004 Mar; 23(11):2107-15. PubMed ID: 15021898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus: induction and control of cell transformation.
    Dolcetti R; Masucci MG
    J Cell Physiol; 2003 Aug; 196(2):207-18. PubMed ID: 12811813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The ubiquitin-proteasome system: the relationship between protein degradation and human diseases].
    Amir R; Ciechanover A; Cohen S
    Harefuah; 2001 Dec; 140(12):1172-6, 1229. PubMed ID: 11789303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ubiquitin/proteasome system in Epstein-Barr virus latency and associated malignancies.
    Dantuma NP; Masucci MG
    Semin Cancer Biol; 2003 Feb; 13(1):69-76. PubMed ID: 12507558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diverse roles for ubiquitin-dependent proteolysis in transcriptional activation.
    Lipford JR; Deshaies RJ
    Nat Cell Biol; 2003 Oct; 5(10):845-50. PubMed ID: 14523392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of proteasomal degradation by the gly-Ala repeat of Epstein-Barr virus is influenced by the length of the repeat and the strength of the degradation signal.
    Dantuma NP; Heessen S; Lindsten K; Jellne M; Masucci MG
    Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8381-5. PubMed ID: 10890896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Regulation of ubiquitin-proteasome dependent muscular proteolysis by hormones and nutrients].
    Attaix D; Combaret L; Taillandier D; Béchet D
    Journ Annu Diabetol Hotel Dieu; 2002; ():123-33. PubMed ID: 12525137
    [No Abstract]   [Full Text] [Related]  

  • 8. Ubiquitin chained and crosslinked.
    Finley D
    Nat Cell Biol; 2002 May; 4(5):E121-3. PubMed ID: 11988752
    [No Abstract]   [Full Text] [Related]  

  • 9. Targeting of host-cell ubiquitin and ubiquitin-like pathways by bacterial factors.
    Boyer L; Lemichez E
    Nat Rev Microbiol; 2004 Oct; 2(10):779-88. PubMed ID: 15378042
    [No Abstract]   [Full Text] [Related]  

  • 10. RNA interference of valosin-containing protein (VCP/p97) reveals multiple cellular roles linked to ubiquitin/proteasome-dependent proteolysis.
    Wójcik C; Yano M; DeMartino GN
    J Cell Sci; 2004 Jan; 117(Pt 2):281-92. PubMed ID: 14657277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteolysis, the ubiquitin-proteasome system, and renal diseases.
    Debigaré R; Price SR
    Am J Physiol Renal Physiol; 2003 Jul; 285(1):F1-8. PubMed ID: 12788783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitination, proteasomes and GABA(A) receptors.
    Lüscher B; Keller CA
    Nat Cell Biol; 2001 Oct; 3(10):E232-3. PubMed ID: 11584285
    [No Abstract]   [Full Text] [Related]  

  • 13. Epstein-Barr virus activates beta-catenin in type III latently infected B lymphocyte lines: association with deubiquitinating enzymes.
    Shackelford J; Maier C; Pagano JS
    Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15572-6. PubMed ID: 14663138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyrrolidine dithiocarbamate and zinc inhibit proteasome-dependent proteolysis.
    Kim I; Kim CH; Kim JH; Lee J; Choi JJ; Chen ZA; Lee MG; Chung KC; Hsu CY; Ahn YS
    Exp Cell Res; 2004 Aug; 298(1):229-38. PubMed ID: 15242777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the ubiquitin/proteasome system in cellular responses to radiation.
    McBride WH; Iwamoto KS; Syljuasen R; Pervan M; Pajonk F
    Oncogene; 2003 Sep; 22(37):5755-73. PubMed ID: 12947384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH; Wolf H; Minarovits J
    Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquilin interacts with ubiquitylated proteins and proteasome through its ubiquitin-associated and ubiquitin-like domains.
    Ko HS; Uehara T; Tsuruma K; Nomura Y
    FEBS Lett; 2004 May; 566(1-3):110-4. PubMed ID: 15147878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stable ubiquitination of human T-cell leukemia virus type 1 tax is required for proteasome binding.
    Chiari E; Lamsoul I; Lodewick J; Chopin C; Bex F; Pique C
    J Virol; 2004 Nov; 78(21):11823-32. PubMed ID: 15479824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor viruses and cell signaling pathways: deubiquitination versus ubiquitination.
    Shackelford J; Pagano JS
    Mol Cell Biol; 2004 Jun; 24(12):5089-93. PubMed ID: 15169876
    [No Abstract]   [Full Text] [Related]  

  • 20. Signaling degradation.
    Kenniston JA; Sauer RT
    Nat Struct Mol Biol; 2004 Sep; 11(9):800-2. PubMed ID: 15332074
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.